In this study, we identify new isoforms of the retinal phosducin and i
nvestigate the expression of the phosducin family, showing that an iso
form, PhLP1, has sequence homology with Phd and G beta gamma binding c
apability, whereas two isoforms (phosducin-like orphan proteins, PhLOP
s) share sequence homology with Phd but fail to bind G beta gamma. Ori
ginal identification of PhLP1 and the PhLOPs was from a human retina c
DNA library, using a PCR product for library hybridization screening t
hat contained a predicted functional epitope domain. The screen identi
fied Phd and three related, but distinct, recombinants (PhLP1, PhLOP1,
and PhLOP2). By RT-PCR, all isoforms are expressed in either retina o
r forskolin-stimulated Y79 retinoblastoma cells; however, the new isof
orms are below the level of detection on Northern blot analysis. The p
redicted amino acid translation of each homologue revealed major diffe
rences, arising from either splice variants or gene duplication of Phd
. To test the functional interaction of all phosducin isoforms with G
beta gamma in vitro, a glutathione S-transferase (GST) fusion protein
was developed for each member. Biochemical interaction with purified r
etinal transducin G beta gamma was verified for GST-Phd and demonstrat
ed for GST-PhLP1; however, neither GST-PhLOP1 nor GST-PhLOP2 bound G b
eta gamma. Comparable results were observed when the GST-phosducin fus
ion proteins selectively sequestered G beta gamma s from retinal extra
cts or when functional G beta gamma interactions were assessed using s
urface plasmon resonance technology. Phosducin and its isoforms are wi
dely distributed in body tissues where they may participate in signal
transduction pathways. Phd and PhLP1 possess an Il-amino acid conserve
d epitope domain (TGPKGVINDWR) that controls the high-affinity binding
of G beta gamma; these isoforms are implicated in the G-protein signa
ling pathway. The phosducin-like orphan proteins (PhLOPs) fail to bind
G beta gamma, suggesting that the PhLOP isoforms may participate in s
till unidentified signaling pathways.